2.8 - 2.9 - Stem cells
Compare the functions of embryonic stem cells, animal tissue stem cells and plant meristems. Follow how cell replacement could restore tissue function and weigh evidence for medical benefits, risks and ethical concerns.
2.8 — Stem cells and meristems
Growth and repair need a continuing supply of new cells. Most specialised cells are already adapted for particular jobs, but stem cells retain two useful abilities.
Stem cell
A stem cell is an unspecialised cell that can divide to make more stem cells and can differentiate into specialised cells.
The balance matters. Some daughter cells remain as stem cells, maintaining the supply, while others differentiate. Differentiation changes a cell so that it becomes specialised for a particular function.
The three sources in this lesson have related but distinct functions:
| Source | Location and range | Function |
|---|---|---|
| Embryonic stem cells | Found in an early embryo; can differentiate into every type of body cell | Supply the many specialised cell types needed as the embryo develops |
| Animal tissue stem cells | Found in particular tissues after embryonic development; usually form a limited range of cell types related to that tissue | Replace cells lost through normal wear or damage, helping to maintain and repair the tissue |
| Plant meristems | Growth regions containing unspecialised cells, including at root and shoot tips | Cells divide to supply new cells; some then differentiate into specialised plant tissues, allowing continued growth |
Animal tissue stem cells are often called adult stem cells, but the name does not mean they occur only in adults. Blood-forming stem cells, for example, are present in bone marrow and produce the specialised cells of blood. Their range is narrower than that of embryonic stem cells.
In plants, a meristem is a region rather than one cell. Continued cell division in meristems supplies cells for new root, shoot and other plant tissues. Cell division supplies new cells, cell elongation increases their size, and differentiation gives them specialised functions. These processes together build a growing plant; differentiation alone is not an increase in length.
2.9 — From stem cell to treatment
If a disease or injury destroys a specialised cell type, replacing those cells could restore some lost function. This is the central potential benefit of stem cells in medicine. Their ability to divide can provide a supply of cells, and their ability to differentiate can provide the required specialised type.
A proposed cell-replacement treatment has to complete a demanding biological route:
- Obtain a suitable source of stem cells.
- Produce enough cells and direct them to differentiate into the required type.
- Deliver the cells to the correct place in the patient.
- Ensure that they survive, integrate with the tissue and perform the required function.
Completing only the first step is not a treatment. Cells of the wrong type, cells in the wrong place or cells that do not function would not repair the tissue.
Blood-forming stem-cell transplantation is an established example. Healthy blood stem cells can be transplanted to replace an unhealthy blood-cell-producing system in some cancers and blood conditions. The transplanted stem cells divide and differentiate to restore production of specialised blood cells.
Other proposed uses include replacing insulin-producing cells lost in diabetes or nerve cells lost in Parkinson's disease. Each particular treatment needs its own evidence of benefit and risk. A treatment being tested in a clinical trial is not automatically proven safe or effective.
An established blood stem-cell transplant shows that stem-cell medicine can work in a suitable context; it does not show that one stem-cell treatment can cure unrelated diseases.
2.9 — Weighing benefits and risks
To discuss a medical use, connect each benefit or risk to the biology and then reach a supported judgement. A list of slogans about stem cells is not enough.
| Potential benefit | Risk, limitation or concern |
|---|---|
| Stem cells may replace damaged or missing specialised cells, potentially restoring tissue function rather than only reducing symptoms. | The cells may differentiate incorrectly, fail to integrate or fail to function, so the treatment may provide no benefit. |
| Embryonic stem cells can produce every body cell type and can supply large numbers of cells. | Any undifferentiated cells left in the transplant may continue dividing and form a tumour. |
| Healthy donor blood stem cells can replace a diseased blood-cell-producing system. | Donor cells may be immunologically incompatible. The recipient may reject cells, or immune cells produced from a donor blood stem-cell transplant may attack the recipient's tissues. |
| A successful transplant may provide long-term replacement because stem cells can keep producing specialised cells. | Treatment that suppresses the immune system can increase infection risk, and living cells may have long-term effects that were not apparent in short studies. |
Embryonic stem-cell use also raises an ethical concern because the cells originate from a very early human embryo. Obtaining these cells usually destroys the embryo. Some people object because they regard the embryo as potential human life; others also raise questions about informed consent from embryo donors. Supporters argue that research and treatment may be justified by the potential to reduce suffering, provided there is informed consent and strict independent oversight. This ethical disagreement is different from a medical side effect, so it should be identified separately.
A sensible judgement depends on the particular proposal: the seriousness of the condition, available alternatives, the source and immune match of the cells, evidence of benefit, tumour and infection risks, long-term monitoring, consent and regulation. For an unproven treatment, a convincing claim is not a substitute for evidence from controlled clinical trials.